vimarsana.com
Home
Live Updates
Mahesh Krishnan Elected to Halozyme's Board of Directors : v
Mahesh Krishnan Elected to Halozyme's Board of Directors : v
Mahesh Krishnan Elected to Halozyme's Board of Directors
/PRNewswire/ -- Halozyme Therapeutics, Inc. (NASDAQ: HALO) ("Halozyme") today announced the election of Mahesh Krishnan, M.D. to its Board of Directors. Dr....
Related Keywords
San Diego ,
California ,
United States ,
Virginia Group ,
Washington ,
Eli Lilly ,
Mahesh Krishnan ,
Bristol Myers Squibb ,
Helen Torley ,
Samantha Gaspar ,
Group Vice ,
Davita Group Vice ,
Acumen Pharmaceuticals ,
Teva Pharmaceuticals ,
Twitter ,
Amgen Inc ,
Nasdaq ,
Global Development Leader For Epogen ,
Pfizer ,
Idorsia Pharmaceuticals ,
Johns Hopkins Carey School Of Business ,
Johns Hopkins University ,
Amgen ,
Davita Venture Group ,
Virginia Nephrology Group ,
Linkedin ,
Jefferson Medical College At Thomas University ,
Corporate Communications ,
Halozyme Therapeutics Inc ,
Pennsylvania State University ,
Exchange Commission ,
Growth At Davita Inc ,
Halozyme Therapeutics ,
Group Vice President ,
Chief Medical ,
Global Development Leader ,
Executive Director ,
Medical Policy ,
Virginia Nephrology ,
Jefferson Medical College ,
Thomas Jefferson ,
Johns Hopkins Carey School ,
Viiv Healthcare ,
Chugai Pharmaceutical ,
Private Securities Litigation Reform Act ,
Although Halozyme ,
Annual Report ,
Investor Relations ,
Nc ,